Papers
1
Total Citations
49
H-Index
1
About
Dr. Qian He is a leading figure in urologic oncology, with a primary focus on advancing surgical treatments for prostate cancer. His most impactful work centers on comparative effectiveness research, where he rigorously evaluates the outcomes of robotic-assisted versus laparoscopic radical prostatectomy. In a landmark 2023 systematic review and meta-analysis—the first to separately analyze randomized controlled trials and non-randomized studies—Dr. He provided critical clarity on this long-debated clinical question. This study, which has already garnered 49 citations, has become an essential reference for surgeons and guideline committees weighing the benefits of minimally invasive approaches. Beyond this flagship paper, Dr. He’s research portfolio consistently bridges evidence-based medicine and surgical innovation, helping to refine best practices in prostate cancer management. His meticulous methodology and commitment to synthesizing high-quality data have established him as a trusted voice in the field. For students and researchers, Dr. He’s work exemplifies how careful meta-analysis can resolve clinical equipoise and directly inform patient care.
Research Focus
Key Achievements
Top Papers
- 1